FDA Proposes New Regulations for Expanded Access to Investigative Drugs
The U.S. Food and Drug Administration (FDA) has submitted two regulatory proposals that would expand the rules concerning who has access to investigative treatments. The new proposals would provide a clearer pathway for certain critically ill patients so they can be considered for access to investigative drugs without enrolling in a clinical trial.
AtlantiCare Medical Center Joins Fox Chase Cancer Center Network
Atlantic City, N.J.-based AtlantiCare Regional Medical Center (ARMC) has joined the Fox Chase Cancer Center Partners network of community hospitals, giving AtlantiCare access to National Cancer Institute approved trials and also gain access to investigator initiated studies as well.
Other breaking news...
Company Profile: An interview with Lydie Hazan, president and chief executive officer, IMPACT Clinical
To read the full articles for this issue or for more information on these and other breaking stories, please click here!